Plant Health Care (LON:PHC) has announced three new Board appointments with effect from 1st November 2019.
Mr Guy van Zwanenberg FCA will join the PHC Board as a Non-executive Director. He will take over as Chair of the Audit Committee and will hold the position of Senior Independent Director. Guy has had a distinguished career as a chartered accountant and finance director and company secretary of listed and unlisted companies. He sits on a number of company boards, including as non-executive chairman of SmartSpace Software plc, and non-executive director of Quixant plc.
Mr Jeffrey Hovey will join the Board as an Executive Director. Jeff Hovey will continue as the Company’s Chief Financial officer, a post he has held since 2013.
Mr Jeffrey Tweedy will join the Board as an Executive Director. Jeff Tweedy will continue as Chief Operating Officer, a post he has held since 2018. Previous to that, he was Commercial Lead, Americas.
Further background details of new Directors and revised membership of Board committees will be accessible on the Company’s website.
Richard Webb, Non-executive Chairman, commented: “We warmly welcome Guy to the Board, where he will bring a wealth of relevant experience. The addition of Jeff Hovey and Jeff Tweedy will ensure that the Board is deeply grounded in the execution of our strategy and will help Chris Richards, the CEO, to drive performance.”
The following details in relation to the appointment of Mr Guy van Zwanenberg (aged 65) are disclosed in accordance with Schedule 2(g) of the AIM Rules:
| Current directorships / partnerships | Directorships / partnerships within the last five years |
| VZ Limited | ICE Marketing Limited |
| Wargrave and Shiplake Regatta Limited | The Powder Byrne Group Limited |
| Quixant Limited | Powder Byrne International Limited |
| Smartspace Software plc | Fast Lane Consulting and Education Services Limited |
| Fast Lane Consulting and Education Services Limited (Ireland) | |
| Thoughts to Treasure Limited | |
| Gamingking Limited |
Mr van Zwanenberg does not hold any shares or options in the Company.
There is no further information to be disclosed in relation to Mr van Zwanenberg’s appointment pursuant to AIM Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.
The following details in relation to the appointment of Mr Jeffrey Hovey (aged 51) are disclosed in accordance with Schedule 2(g) of the AIM Rules:
Mr Hovey has an interest of nil ordinary shares (“Ordinary Shares”) in the capital of Plant Health Care and holds options of 1,028,870 exercisable at a range of 20 – 25 pence per Ordinary Share. The options are exercisable up to 10 years from his commencement and the vesting period ranges from immediate to 3 years.
There is no further information to be disclosed in relation to Mr Hovey’s appointment pursuant to AIM Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.
The following details in relation to the appointment of Mr Jeffrey Tweedy (aged 52) are disclosed in accordance with Schedule 2(g) of the AIM Rules:
Mr Tweedy has an interest of 17,904 ordinary shares of 20 pence each (“Ordinary Shares”) in the capital of Plant Health Care and holds options of 1,229,359 exercisable at 24 pence per Ordinary Share. The options are exercisable up to 10 years from his commencement and the vesting period ranges from immediate to 3 years.
There is no further information to be disclosed in relation to Mr Tweedy’s appointment pursuant to AIM Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.
